Haleon Revenue

Haleon had revenue of 2.78B GBP in the quarter ending September 30, 2024, a decrease of -0.64%. This brings the company's revenue in the last twelve months to 11.24B, down -0.65% year-over-year. In the year 2023, Haleon had annual revenue of 11.30B with 4.09% growth.

Revenue (ttm)

11.24B

Revenue Growth

-0.65%

P/S Ratio

3.00

Revenue / Employee

442.38K

Employees

25,408

Market Cap

33.25B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	11.30B	444.00M	4.09%
Dec 31, 2022	10.86B	1.31B	13.76%
Dec 31, 2021	9.55B	-347.00M	-3.51%
Dec 31, 2020	9.89B	1.41B	16.65%
Dec 31, 2019	8.48B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	38.20B
GSK plc	31.31B
Smith & Nephew	4.46B
ConvaTec Group	1.74B
Hikma Pharmaceuticals	2.39B
HUTCHMED (China)	483.31M
Oxford Nanopore Technologies	167.75M
Indivior	881.89M

Revenue Rankings

Haleon News

5 days ago - Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3% - GuruFocus
6 days ago - Pfizer Sells Stake in Haleon, Reduces Holding to 7.3% - GuruFocus
6 days ago - Pfizer Sells Stake in Haleon for $3.05 Billion - GuruFocus
6 days ago - Pfizer Sells 700 Million Haleon Shares for $3 Billion - The Wall Street Journal
6 days ago - Pfizer Sells 700 Million Haleon Shares for $3 Billion - WSJ
6 days ago - Pfizer Sells 700 Million Haleon Shares for $3.05 Billion - The Wall Street Journal
7 days ago - Pfizer to cut Haleon stake in 700M share sale - Seeking Alpha
7 days ago - Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner - Reuters

More News